PTGDS and diffuse large B-cell lymphoma: Collectively, these findings provided evidence that PTGDS inhibition could sensitize DLBCL cells to chemotherapeutic drugs through promoting DNA damage, and further in-vivo studies were needed to confirm the effect of AT56 on chemo-sensitivity in DLBCL.